中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 药理学第一研究室
Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages

文献类型：期刊论文

作者Yan, Yu-xi2,3; Shao, Mei-juan1; Qi, Qing2; Xu, Yan-sheng1; Yang, Xiao-qian2; Zhu, Feng-hua2; He, Shi-jun2; He, Pei-lan2; Feng, Chun-lan2; Wu, Yan-wei2
刊名ACTA PHARMACOLOGICA SINICA
出版日期2018-10
卷号39期号:10页码:1633-1644
关键词SM934 artemisinin analogue ulcerative colitis inflammatory bowel disease (IBD) neutrophils macrophage NF-kappa B RAW 2647 cells THP-1-derived macrophages
ISSN号1671-4083
DOI10.1038/aps.2017.185
文献子类Article
英文摘要Ulcerative colitis (UC) is a chronic, nonspecific inflammatory bowel disease (IBD) characterized by complicated and relapsing inflammation in the gastrointestinal tract. SM934 is a water-soluble artemisinin analogue that shows anti-inflammatory and immuno-regulatory effects. In this study, we investigated the effects of SM934 on UC both in vivo and in vitro. A mouse model of colitis was established in mice by oral administration of 5% dextran sulfate sodium (DSS). SM934 (3, 10 mg/kg per day, ig) was administered to the mice for 10 days. After the mice were sacrificed, colons, spleens and mesenteric lymph nodes (MLNs) were collected for analyses. SM934 administration restored DSS-induced body weight loss, colon shortening, injury and inflammation scores. Furthermore, SM934 administration significantly decreased the disease activity index (DAI), histopathological scores, and myeloperoxidase (MPO) activities in colonic tissues. Moreover, SM934 administration dose-dependently decreased the mRNA and protein levels of DSS-induced pro-inflammatory cytokines (IL-1 beta, IL-6 and TNF-alpha), and the percentage of macrophages and neutrophils in colon tissues. The effects of SM934 on LPS-stimulated RAW 264.7 cells and THP-1-derived macrophages were examined in vitro. Treatment with SM934 (0.8, 8, 80 mu mol/L) dose-dependently decreased the production of pro-inflammatory mediators in LPS-stimulated RAW 264.7 cells and THP-1-derived macrophages via inhibiting activation of the NF-kappa B signaling. Our results reveal the protective effects of SM934 on DSS-induced colitis can be attributed to its suppressing effects on neutrophils and macrophages and its inhibitory role in the NF-kappa B signaling, suggests that SM934 might be a potential effective drug for ulcerative colitis.
WOS关键词INFLAMMATORY-BOWEL-DISEASE ; NF-KAPPA-B ; SODIUM-INDUCED COLITIS ; NLRP3 INFLAMMASOME ; MURINE COLITIS ; MICE ; ACTIVATION ; MONOCYTES ; CYTOKINES ; MUCOSA
资助项目"Personalized Medicines Molecular Signature-based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020107] ; National Science & Technology Major Project "New Drug Creation and Manufacturing Program", China[2017ZX09101002-002-010] ; National Natural Science Foundation of China (NSFC)[81673445]
WOS研究方向Chemistry ; Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000448391500009
出版者ACTA PHARMACOLOGICA SINICA
源URL[http://119.78.100.183/handle/2S10ELR8/279556]  
专题药理学第一研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Tang, Wei; Zuo, Jian-ping
作者单位1.Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China;
3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China;
推荐引用方式
GB/T 7714		 Yan, Yu-xi,Shao, Mei-juan,Qi, Qing,et al. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages[J]. ACTA PHARMACOLOGICA SINICA,2018,39(10):1633-1644.
APA Yan, Yu-xi.,Shao, Mei-juan.,Qi, Qing.,Xu, Yan-sheng.,Yang, Xiao-qian.,...&Zuo, Jian-ping.(2018).Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages.ACTA PHARMACOLOGICA SINICA,39(10),1633-1644.
MLA Yan, Yu-xi,et al."Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages".ACTA PHARMACOLOGICA SINICA 39.10(2018):1633-1644.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。